Curcumin has been shown to be able to sensitize TRAIL-resistant prostate cancer cells to TRAIL through the upregulation of death receptors death receptor 4 (DR4), death receptor 5 (DR5) and inhibited angiogenesis [164]. This evidence concerns the gene TNFRSF10A and prostate carcinoma.